Predictors for PaO2and hypoxemic respiratory failure in COPD-A three-year follow-up

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 11, Issue 5, 2014, Pages 531-538

  Saure, E W ^a,b   Eagan, T M L ^a,b   Jensen, R L ^c   Bakke, P S ^a   Johannessen, A ^b   Aanerud, M ^b   Nilsen, R M ^b   Thorsen, E ^a   Hardie, J A ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Arterial blood gases; Longitudinal study; Lung function; Risk factor

Indexed keywords

ANTIBIOTIC AGENT; OXYGEN; STEROID;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD GAS ANALYSIS; BODY COMPOSITION; CARDIOMETABOLIC RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE EXACERBATION; FAT MASS; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; HYPERINFLATION; HYPOXEMIA; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; RESPIRATORY FAILURE; RESTING HEART RATE; SMOKING HABIT; TOTAL LUNG CAPACITY; ANOXIA; BLOOD; CARDIOVASCULAR DISEASE; COMPLICATION; DISEASE COURSE; INFLAMMATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PRESSURE; RESPIRATORY INSUFFICIENCY; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ANOXIA; BLOOD GAS ANALYSIS; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXYGEN; PARTIAL PRESSURE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOTAL LUNG CAPACITY;

EID: 84907051384     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2014.898027     Document Type: Article

References (26)

1. Zielinski J, MacNee W, Wedzicha J, et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis 1997; 52:43-47.
2. Nizet TA, van den Elshout FJ, Heijdra YF, van de Ven MJ, Mulder PG, Folgering HT. Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia. Chest 2005; 127:1904-1910.
3. Costello R, Deegan P, Fitzpatrick M, McNicholas WT. Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med 1997; 102:239-244.
4. Banchero N. Cardiovascular responses to chronic hypoxia. Annu Rev Physiol 1987; 49:465-476.
5. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008; 32:1371-1385.
6. Macnee W, Maclay J, McAllister D. Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Th orac Soc 2008; 5:824-833.
7. Kent BD, Mitchell PD, McNicholas WT. Hypoxemia in patients with COPD: cause, eff ects, and disease progression. Int J Chron Obstruct Pulmon Dis 2011; 6:199-208.
8. Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008; 3:637-658.
9. Sandek K, Bratel T, Lagerstrand L, Rosell H. Relationship between lung function, ventilation-perfusion inequality and extent of emphysema as assessed by high-resolution computed tomography. Respir Med 2002; 96:934-943.
10. Barbera JA, Roca J, Ferrer A, et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1997; 10:1285-1291.
11. Saure EW, Eagan TM, Jensen RL, et al. Explained variance for blood gases in a population with COPD. Clin Respir J 2012; 6:72-80.
12. Kim DK, Jacobson FL, Washko GR, et al. Clinical and radiographic correlates of hypoxemia and oxygen therapy in the COPDGene study. Respir Med 2011; 105:1211-1221.
13. Eagan TM, Ueland T, Wagner PD, et al. Systemic infl ammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J 2010; 35:540-548.
14. Pauwels R, Committee GOLD. Workshop Report: 2005 Update, of a 1998 NHLBI/WHO workshop. Global Strategy for Diagnosis, Management, and Prevention of COPD. 2005
15. Eagan TM, Gabazza EC, D'Alessandro-Gabazza C, et al. TNFalpha is associated with loss of lean body mass only in already cachectic COPD patients. Respir Res 2012; 13:48.
16. Cerveri I, Zoia MC, Fanfulla F, et al. Reference values of arterial oxygen tension in the middle-aged and elderly. Am J Respir Crit Care Med 1995; 152:934-941.
17. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359:1543-1554.
18. Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011; 365:1184-1192.
19. Rodriguez-Roisin R, Drakulovic M, Rodriguez DA, Roca J, Barbera JA, Wagner PD. Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J Appl Physiol 2009; 106:1902-1908.
20. O'Donnell DE, Parker CM. COPD exacerbations. 3: Pathophysiology. Th orax 2006; 61:354-361.
21. Holley HS, Milic-Emili J, Becklake MR, Bates DV. Regional distribution of pulmonary ventilation and perfusion in obesity. J Clin Invest 1967; 46:475-481.
22. Heindl S, Lehnert M, Criee CP, Hasenfuss G, Andreas S. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 2001;164:597-601.
23. Volterrani M, Scalvini S, Mazzuero G, et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest 1994; 106:1432-1437.
24. Al-Ashkar F, Mehra R, Mazzone PJ. Interpreting pulmonary function tests: recognize the pattern, and the diagnosis will follow. Cleve Clin J Med 2003; 70:866, 868, 871-866, 3, passim.
25. Johannessen A, Lehmann S, Omenaas ER, Eide GE, Bakke PS, Gulsvik A. Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 2006; 173:1316-1325.
26. Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Offi cial Statement of Th e European Respiratory Society. Eur Respir J 1995; 8:492-506.